Sökning: onr:"swepub:oai:DiVA.org:umu-212400" >
Warfarin treatment ...
-
Welander, FridaUmeå universitet,Institutionen för folkhälsa och klinisk medicin,Umeå Univ, Dept Publ Hlth & Clin Med, Dept Res & Dev Sundsvall, Lasarettsvagen 21, S-85643 Sundsvall, Sweden.
(författare)
Warfarin treatment quality and outcomes in patients with non-valvular atrial fibrillation and CKD G3-G5D
- Artikel/kapitelEngelska2023
Förlag, utgivningsår, omfång ...
-
Elsevier,2023
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:umu-212400
-
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-212400URI
-
https://doi.org/10.1016/j.thromres.2023.07.003DOI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-510648URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Introduction: Warfarin treatment quality is calculated as time in therapeutic range (TTR). TTR ≥ 70 % is considered reducing the risk of adverse events for patients with atrial fibrillation (AF). The association of TTR and adverse events in chronic kidney disease (CKD) is however poorly investigated. The aim is to explore this further.Materials and methods: Swedish cohort study based on national healthcare registers between 2009 and 2018, including Swedish Renal Registry, Swedish Stroke Register and AuriculA - the Swedish national quality register for AF and anticoagulation. Investigating the effect of individual TTR (iTTR) and iTTR ≥ 70 % versus <70 % on the risk of ischemic stroke, major bleeding and death for patients with CKD GFR category 3–5 (G3-G5) including patients on dialysis (G5D) and non-valvular AF (NVAF).Results: Of 2379 included patients 21.9 % had G3, 47.5 % G4, 10.8 % G5 and 19.8 % G5D. TTR in G3 was 75.6 %, G4 72.2 %, G5 67.6 % and G5D 62.0 %. Increase by 10 percentage points iTTR conferred lower risk of major bleeding, ischemic stroke and death for all patients (hazard ratio 0.91 (95 % Confidence interval 0.87–0.94), 0.92 (0.85–0.99) and 0.88 (0.85–0.90)). iTTR≥ 70 % versus <70 % was associated with lower risk of bleeding and death in all patients (0.63 (0.51–0.77) and (0.51 (0.43–0.61)), and a non-significant tendency towards lower stroke risk (0.67 (0.43–1.06)).Conclusions: Warfarin treatment quality worsens with decreasing GFR. Higher iTTR confers lower risk of bleeding, ischemic stroke and death in patients with NVAF and G3-G5D. iTTR ≥ 70 % was associated with better safety profile. Close monitoring of patients with CKD on warfarin is recommended.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Renlund, Henrik,1979-Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Uppsala Univ, Uppsala Clin Res Ctr, Uppsala Sci Pk,Dag Hammarskjolds Vag 38, S-75185 Uppsala, Sweden.(Swepub:uu)henre358
(författare)
-
Dimény, EmökeUmeå universitet,Institutionen för folkhälsa och klinisk medicin,Umeå Univ, Dept Publ Hlth & Clin Med, S-90187 Umeå, Sweden.(Swepub:umu)emdi0006
(författare)
-
Holmberg, Henrik,1976-Umeå universitet,Institutionen för epidemiologi och global hälsa,Institutionen för folkhälsa och klinisk medicin,Umeå Univ, Dept Epidemiol & Global Hlth, S-90187 Umeå, Sweden.(Swepub:umu)hekhog02
(författare)
-
Själander, AndersUmeå universitet,Institutionen för epidemiologi och global hälsa,Umeå Univ, Dept Epidemiol & Global Hlth, S-90187 Umeå, Sweden.
(författare)
-
Umeå universitetInstitutionen för folkhälsa och klinisk medicin
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Thrombosis Research: Elsevier229, s. 131-1380049-38481879-2472
Internetlänk
Hitta via bibliotek
Till lärosätets databas